Skip to main content
Clinical Trials/NCT00458419
NCT00458419CompletedNot Applicable

Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease

Dartmouth-Hitchcock Medical Center1 site in 1 country17 target enrollmentStarted: September 2005Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
17
Locations
1
Primary Endpoint
Slope of oxygen consumption - dyspnea during treadmill exercise.

Study Overview

Brief Summary

Endorphins are naturally occurring narcotic substances that are released when individuals perform exercise. The hypothesis of the study is that endorphins reduce the severity of breathlessness during exercise in patients with chronic obstructive pulmonary disease (COPD). The initial five visits include familiarization and validation of a computerized system for patients to report dyspnea and leg discomfort continuously during exercise testing.

At Visits 6 and 7 blood is drawn to measure serum endorphin levels pre-exercise, end exercise, and 30 minutes after exercise. Normal saline or naloxone is given intravenously 5 minutes prior to exercise in a double-blinded design. The primary outcome is the slope of oxygen consumption - dyspnea.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Diagnostic
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
50 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of COPD
  • Ability to exercise
  • Ability to computer mouse to provide ratings
  • > 10 pack-years smoking
  • Baseline dyspnea index < 9

Exclusion Criteria

  • Clinically significant comorbidities

Arms & Interventions

A: naloxone; B: normal saline

Placebo Comparator

Arm A: IV naloxone Arm B: IV normal saline

Intervention: naloxone versus placebo (Drug)

A: naloxone; B: normal saline

Placebo Comparator

Arm A: IV naloxone Arm B: IV normal saline

Intervention: intravenous injection of normal saline or naloxone (Drug)

Outcomes

Primary Outcomes

Slope of oxygen consumption - dyspnea during treadmill exercise.

Time Frame: throughout exercise

Secondary Outcomes

  • Exercise duration(10-14 minutes)
  • Peak ratings of breathlessness(at end of exercsie - 10-15 minutes)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Role of Endorphins in the Perception of... | Clinical Trial